Supernus Announces Issuance of Sixth U.S. Patent Protecting Oxtellar XR®
ROCKVILLE, Md., June 02, 2016 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, today announced the …